Loading
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (3 ops.)
Latest filing published 10 Sept 2026 for Aquestive Therapeutics, Inc., €1,892. Read the official filing
Filing timeline
BuySalePeter E. Boyd
Insider track record
Disclosed buys
2
Disclosed sells
3
T+90 hit rate
100%
T+90 mean return
+74.2%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Peter E. Boyd: trading record in brief
Peter E. Boyd appears in our data through filings on Aquestive Therapeutics, Inc. shares, published by SEC (Form 4). In total, 12 filings cover trades dated from 8 June 2022 to 9 September 2026.
Market trades split into 2 purchases (€5,933) and 3 sales (€182k). Taken together, the sales exceed the purchases by €176k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 7 share grants.
The record was last updated on 10 September 2026 with a share grant (€1,892) in Aquestive Therapeutics, Inc. The last purchase on record was published on 15 June 2022, which is 1,586 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Peter E. Boyd
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations12 total
2,293 shares@ US$0.96Common StockSEC:0001214659-26-011541:0
80,000 shares0Common StockSEC:0001214659-26-003147:0
20,000 shares0Common StockSEC:0001214659-25-017652:0
10,000 shares@ US$7.000.013% mcap16.2% of flowCommon StockSEC:0001214659-25-015046:0
10,000 shares@ US$6.300.012% mcap14.6% of flowCommon StockSEC:0001214659-25-014287:0
15,000 shares@ US$5.300.015% mcap18.4% of flowCommon StockSEC:0001214659-25-013485:0
80,000 shares0Common StockSEC:0001214659-25-004222:0
8,370 shares@ US$4.889.1% of flowCommon StockSEC:0001214659-24-004394:0
86,250 shares0Common StockSEC:0001214659-24-004303:0
100,000 shares0Common StockSEC:0001214659-23-003695:0
5,000 shares@ US$0.811.7% of flowCommon StockSEC:0001628280-22-017186:0
Canonical exit: 12 Sept 2022 (T+90)
2,293 shares@ US$0.960.9% of flowCommon StockSEC:0001628280-22-016872:0
Canonical exit: 6 Sept 2022 (T+90)
12 of 12 declarations
